Today: 28 January 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

iPhone 17 Is Here: Bigger, Brighter, Smarter — and Finally 120Hz Without Going Pro

iPhone 17 Is Here: Bigger, Brighter, Smarter — and Finally 120Hz Without Going Pro

Key facts (Sept 9, 2025): In-depth report What’s new at a glance Apple’s iPhone 17 is the most substantial upgrade to the standard iPhone in years, headlined by a larger 6.3-inch displaythat finally brings ProMotion 120Hz to the non-Pro tier. Apple pairs the panel with Ceramic Shield 2, claiming 3× better scratch resistance and improved anti-reflection — changes you’ll notice both in daily scuff resistance and outdoor legibility…
9 September 2025
··
Flagship Face-Off 2025: OnePlus 13 Pro vs Xiaomi 15 Pro vs Realme GT7 Pro

OnePlus in 2025: Evolution of the “Flagship Killer” – 15 Key Facts You Need to Know

Conclusion: As of September 2025, OnePlus has transformed from an upstart “flagship killer” to a multifaceted brand offering everything from budget phones to ultra-premium flagships and ecosystem devices. Its phones combine bleeding-edge hardware (fastest chips, huge RAM, super-fast charging) with a refined OxygenOS experience that caters to both enthusiasts and general users. The company’s evolution hasn’t been without growing pains…
9 September 2025
Nikon D810A in 2025: Astrophotography Beast or Outshined by Modern Cameras?

Nikon D810A in 2025: Astrophotography Beast or Outshined by Modern Cameras?

Introduction In early 2015, Nikon surprised the astronomy and photography world by “aiming for the stars” with the D810A, a specialized version of its D810 DSLR designed exclusively for astrophotography Dpreview. This camera looked almost identical to a standard D810 on the outside, but its internals were tweaked for the night sky. Nikon equipped the D810A with a modified infrared-cut…
9 September 2025
Nikon Z6 III Review: 6K Video, 120fps Bursts & Next-Level Autofocus

Nikon Z6 III Review: 6K Video, 120fps Bursts & Next-Level Autofocus

Key Facts General Overview and Positioning The Nikon Z6 III sits in the sweet spot of Nikon’s full-frame Z series, positioned as a versatile enthusiast/prosumercamera that can handle just about anything. It succeeds the Z6 II (2020) and original Z6 (2018) as Nikon’s mid-range 24MP model, but elevates the line into a higher class. In fact, with its $2,500 price and beefed-up specs, the Z6 III…
9 September 2025
7K RAW, Under $4K – Canon’s Rumored EOS C50 is a Compact Indie Cinema Powerhouse Ready to Rival Sony’s FX3

7K RAW, Under $4K – Canon’s Rumored EOS C50 is a Compact Indie Cinema Powerhouse Ready to Rival Sony’s FX3

Key Facts Compact Cinematic Specs in Detail 7K Full-Frame Sensor & 4K High Frame Rates: At the heart of the EOS C50 is a rumored 32.3-megapixel full-frame CMOS sensor – a significant step up in resolution compared to the 20MP Super35 sensor in the C70 and the 12MP sensor of Sony’s FX3. This high-res chip enables 7K internal recording for maximum detail. In fact, the…
9 September 2025
Sony’s 200MP Phone Camera Bombshell Set to Crush Samsung – Meet the IMX903 Sensor

Sony’s 200MP Phone Camera Bombshell Set to Crush Samsung – Meet the IMX903 Sensor

Key Facts Sony’s 200MP IMX903 Sensor – Specs & Breakthroughs Sony’s new 200MP smartphone sensor – purportedly the IMX903 – is generating buzz as a potential game-changer in mobile photography. According to reliable leaker Digital Chat Station, this sensor packs 200 million pixels on a generous 1/1.12″ sensor die Notebookcheck Androidheadlines. In plain terms, the IMX903 will be one of the largest smartphone camera sensors ever, narrowly trailing “1-inch”…
9 September 2025
·
PS6 Leak Bombshell: Modular Console, Handheld Surprise, and 2028 Release – Everything We Know So Far

PS6 Leak Bombshell: Modular Console, Handheld Surprise, and 2028 Release – Everything We Know So Far

Confirmed News & Official Hints (What We Do Know) In an official sense, Sony has not announced the PlayStation 6 – but there are plenty of clues that it’s deep in the works. For starters, Sony has proactively trademarked the names “PS6” through “PS10” in Japan, ensuring nobody else can snag those labels Gamingbible. This is standard practice (they trademarked…
8 September 2025
Astro Showdown: Sony vs Canon vs Nikon – Best Cameras for Shooting the Stars in 2025

Battle of the 2025 Tablets: Samsung vs Apple vs Lenovo – Ultimate Flagship-to-Budget Showdown

Key Facts at a Glance Now let’s dive into the detailed comparison of each brand’s tablet family – from design and displays to performance, battery life, software, and unique features – and see how they stack up in 2025. Samsung Tablets in 2025 Samsung has built a diverse Galaxy Tab lineup, from ultra-premium productivity machines to affordable media slates. In…
8 September 2025
··
Astro Showdown: Sony vs Canon vs Nikon – Best Cameras for Shooting the Stars in 2025

Astro Showdown: Sony vs Canon vs Nikon – Best Cameras for Shooting the Stars in 2025

Key Facts Astrophotography demands a unique blend of camera capabilities: superb high-ISO performance, low thermal noise in long exposures, generous dynamic range, and practical features for shooting in darkness (from backlit buttons to night-vision live displays). In this report, we compare how the big three camera makers – Sony, Canon, and Nikon – stack up in the current market (DSLRs and mirrorless…
8 September 2025
1 … 480 481 482 483 484 … 584

Stock Market Today

  • AstraZeneca Stock Seen 7.6% Undervalued Amid Strong Pipeline and Recent Gains
    January 28, 2026, 5:12 AM EST. AstraZeneca (LSE:AZN) shares have gained 10.51% over three months, with a one-year total shareholder return of 26.95%, highlighting rising investor interest. Trading at £138.80 and estimated 7.6% undervalued against a £150.26 fair value, the company's robust late-stage pipeline - focused on oncology, rare diseases, and cardiovascular therapies - underpins growth forecasts. Analysts expect over $10 billion in peak risk-adjusted revenues from new products, supporting future earnings expansion. However, high valuation with a 31.6x price-to-earnings ratio versus European pharma average of 25.9x raises caution, alongside risks like patent expirations, biosimilar competition, and government price controls. Investors can explore personalized valuation models to assess AstraZeneca's outlook amid evolving market dynamics.
Go toTop